Silvia Reyes-Maya

Silvia Reyes-Maya

Auto-generated profile, based on publicly available information

Silvia Reyes-Maya

Universidad Nacional Autónoma de México. Facultad de Medicina Veterinaria y Zootecnia. Departamento de Medicina, Cirugía y Zootecnia para Pequeñas Especies. Ciudad de México, México

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2025 in Veterinaria México OA
Verified
Journal Article
Open access
PDF file
SRSilvia Reyes-Maya
Silvia Reyes-Maya
AGAmanda Gayosso-Vázquez
Amanda Gayosso-Vázquez
VRVianey Ramirez-Andoney
Vianey Ramirez-Andoney
PRPablo Pintor Ríos
Pablo Pintor Ríos
MEMaría Luisa Escobar
María Luisa Escobar
RARogelio Alejandro Alonso
Rogelio Alejandro Alonso
Reproductive control of invasive, feral, and domesticated animals is an urgent public health issue. Immunological vaccines are employed as an emerging strategy to target different components of the reproductive system, to achieve immunocastration. Successful use of immunogens against parts of the oocyte, spermatozoon, gonadotropin-releasing hormone (GnRH), and luteinizing hormone receptor (LHr) has been reported. In this work, a recombinant DNA vaccine was prepared (P2GnRHrP30) by the fusion of the first extracellular domain of the canine GnRH receptor (GNRHr) gene to the P2 and P30 tetanus toxoid epitopes. This construction was cloned in the pCI-NEO mammalian expression vector and evaluated as an immunocontraception DNA vaccine in male mice. The developed vaccine was demonstrated to be safe, and capable of reducing serum testosterone levels and causing testicular atrophy. Our work indicates that the first extracellular domain of the GnRHr gene may act as an immune target for reproductive control and potentially be used as a non-surgical sterilization procedure in mammals.